| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000018393 |
| Receipt No. | R000021299 |
| Official scientific title of the study | Investigation of fixation behavior during the perimetry test |
| Date of disclosure of the study information | 2015/07/23 |
| Last modified on | 2016/05/24 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | Investigation of fixation behavior during the perimetry test | |
| Title of the study (Brief title) | Fixation behavior during the perimetry test | |
| Region |
|
|
| Condition | ||
| Condition | healthy participants | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluated the fixation behavior during the perimetery test. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | fixation behavior |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | astigmatic power is less than 1.50D,
intraocular pressure is less than 21mmHg, visual acuity more than 1.0. |
|||
| Key exclusion criteria | astigmatic power is more than 1.50D,
intraocular pressure is more than 22mmHg, visual acuity is less than 0.9. |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Nobuyuki Shoji |
| Organization | School of Allied Health Sciences, Kitasato University |
| Division name | Orthoptics and Visual Science |
| Address | 1-15-1, Kitasato, Minami-ku,Sagamihara ,Kanagawa, Japan |
| TEL | 0.42-778-9671 |
| nshoji@ahs.kitasato-u.ac.jp | |
| Public contact | |
| Name of contact person | Kazunori Hirasawa |
| Organization | School of Allied health sciences, KITASATO University |
| Division name | Orthoptics and Visual Science |
| Address | 1-15-1, Kitasato, Minami-ku,Sagamihara ,Kanagawa, Japan |
| TEL | 042-778-9671 |
| Homepage URL | |
| hirasawa@kitasato-u.ac.jp | |
| Sponsor | |
| Institute | School of Allied Health Sciences, Kitasato University |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | School of Allied Health Sciences, Kitasato University |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| URL releasing results | |
| Results | |
| Other related information | case control study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021299 |